JOY ALLEN: Open Payments
NPI 1023663150 · CENTRE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 38 payments from 17 companies in 2025. Trend: 2023 $1,081 · 2024 $952 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Dexcom, Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Astellas Pharma US Inc | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Philips North America LLC | 2 | $30 |
| Novo Nordisk Inc | 2 | $29 |
| Lundbeck LLC | 1 | $21 |
Products named: NURTEC ODT, Kerendia, Dexcom G6 Transmitter, CAPLYTA, BREZTRI, REXULTI, Veozah, JARDIANCE.
Industry payments across AL — which companies pay providers there.
